Pharmaceutical - USA, Pfizer

Filter

Current filters:

USAPfizer

Popular Filters

1 to 25 of 36 results

Pfizer beats sales and earnings forecast for the third quarter

Pfizer beats sales and earnings forecast for the third quarter

28-10-2014

US pharma giant Pfizer has beaten the forecasts for both its sales and its earnings for the third quarter…

FinancialLyricaPfizerPharmaceuticalUSAViagra

Pfizer to finally drop Remoxy development

27-10-2014

Shares of Durect Corp plunged 42.9% to $0.79 after it revealed that pharma giant Pfizer has decided to…

DurectLicensingNeurologicalPain TherapeuticsPfizerPharmaceuticalPosidurRemoxyUSA

US FDA backs abuse deterrent labeling for Pfizer’s Embeda ER

19-10-2014

The US Food and Drug Administration has approved an updated label for pharma giant Pfizer’s Embeda…

AvinzaEmbedaNeurologicalPfizerPharmaceuticalRegulationUSA

US FDA panel votes to keep Chantix black box warning; staffers recommend secukinumab

US FDA panel votes to keep Chantix black box warning; staffers recommend secukinumab

17-10-2014

The US Food and Drug Administration's advisory panel has voted to keep a black box warning on US pharma…

ChantixNovartisPfizerPharmaceuticalRegulationsecukinumabUSA

Pfizer’s palbociclib gains FDA Priority Review

13-10-2014

Pfizer says that the New Drug Application for its investigational breast cancer treatment palbociclib…

OncologypalbociclibPfizerPharmaceuticalRegulationUSA

Pfizer and Kyowa Hakko collaborate on immuno-oncology combination study

Pfizer and Kyowa Hakko collaborate on immuno-oncology combination study

30-09-2014

US pharma major Pfizer and Japanese drugmaker Kyowa Hakko Kirin have entered into an agreement to explore…

ImmunologicalsKyowa Hakko KirinmogamulizumabOncologyPF-05082566PfizerPharmaceuticalResearchUSA

Actavis approached by Pfizer in latest takeover deal, according to sources

Actavis approached by Pfizer in latest takeover deal, according to sources

24-09-2014

US pharma giant Pfizer has held talks regarding an acquisition of Ireland-headquartered generics major…

ActavisMergers & AcquisitionsPfizerPharmaceuticalUSA

FDA approves Elelyso for pediatric use in Gaucher disease

FDA approves Elelyso for pediatric use in Gaucher disease

29-08-2014

The US Food and Drug Administration has approved US pharma giant Pfizer’s Elelyso (taliglucerase alfa)…

ElelysoPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesRegulationUSA

ViiV Healthcare gains FDA approval for HIV drug Triumeq

ViiV Healthcare gains FDA approval for HIV drug Triumeq

23-08-2014

The US Food and Drug Administration has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine…

Anti-viralsGlaxoSmithKlinePfizerPharmaceuticalRegulationShionogiTriumeqUSAViiV Healthcare

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

22-08-2014

While speculation continues as to whether Pfizer will resume its attempts to buy AstraZeneca, Pfizer…

ActavisAstraZenecaBusiness FinanceIrelandMergers & AcquisitionsPfizerPharmaceuticalSwedenUKUnited StatesUSA

FDA expands indication for Eliquis to treatment of DVT and PE

FDA expands indication for Eliquis to treatment of DVT and PE

22-08-2014

US pharma majors Bristol-Myers Squibb and Pfizer late yesterday said that the US Food and Drug Administration…

Boehringer IngelheimCardio-vascularEliquisPfizerPharmaceuticalPulmonary embolismRegulationUSA

Pfizer files palbociclib NDA with FDA for breast cancer

Pfizer files palbociclib NDA with FDA for breast cancer

19-08-2014

US pharma giant Pfizer says it has completed the submission of a New Drug Application to the US Food…

OncologypalbociclibPfizerPharmaceuticalRegulationUSA

Pfizer’s meningococcal B vaccine BLA accepted; gains priority review

Pfizer’s meningococcal B vaccine BLA accepted; gains priority review

15-08-2014

The US Food and Drug Administration has accepted for review the Biologics License Application for bivalent…

Invasive meningococcal diseaseLP2086PfizerPharmaceuticalRegulationrLP2086USAVaccines

Pfizer agrees to pay $35 million for improper marketing of Rapamune

Pfizer agrees to pay $35 million for improper marketing of Rapamune

07-08-2014

US pharma giant Pfizer has reached a $35 million settlement with 41 states in the USA and the District…

LegalPfizerPharmaceuticalRapamuneUSA

Pfizer spends $635 million on acquiring two Baxter vaccines

Pfizer spends $635 million on acquiring two Baxter vaccines

30-07-2014

US pharma giant Pfizer has entered into a definitive agreement to acquire Baxter International portfolio…

Baxter InternationalMergers & AcquisitionsPfizerPharmaceuticalProductionUSAVaccines

Earnings at Pfizer tank but still just beat expectations

Earnings at Pfizer tank but still just beat expectations

29-07-2014

Taking the brunt of generic competition to former blockbuster drugs, US pharma giant Pfizer posted a…

FinancialPfizerPharmaceuticalUSA

Pfizer’s BeneFIX reduces bleeding rates in Ph III study

Pfizer’s BeneFIX reduces bleeding rates in Ph III study

16-07-2014

US pharma giant Pfizer today released positive results of a Phase III study comparing a prophylaxis regimen…

BenefixHaemophiliaHematologyHemophilia BPfizerPharmaceuticalResearchSevere hemophilia BUSA

Varenicline combined with nicotine patch improves smoking cessation rates

Varenicline combined with nicotine patch improves smoking cessation rates

09-07-2014

Combining the smoking cessation medication varenicline with nicotine replacement therapy was more effective…

ChantixNeurologicalNicotinePfizerPharmaceuticalResearchSmoking cessationUSAVarenicline

Pfizer agrees to pay $325 million over Neurontin

Pfizer agrees to pay $325 million over Neurontin

03-06-2014

US pharma giant Pfizer has agreed a $325 million settlement over a trial regarding the marketing of Neurontin…

CNS DiseasesLegalNeurontinPfizerPharmaceuticalUSA

1 to 25 of 36 results

Parexel

Parexel

Back to top